Notably, this C1Q signature was linked to a poor prognosis in clear-cell renal cell carcinoma 22, but CXCL9 attracts CD8+ cytotoxic T cells and is associated with better outcomes 23. This evidence concerns the gene CD8A and clear cell renal carcinoma.